pharma · Dry Eye · Conjunctivitis, Allergic · ALDX
Aldeyra Therapeutics
Aldeyra Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
131 Hartwell Avenue, Suite 320, Lexington, Massachusetts 02421, US HQ
2004 Founded
14 Employees
Public company Type
ALDX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 131 Hartwell Avenue, Suite 320, Lexington, Massachusetts 02421, US
- Founded
- 2004
- Employees
- 14
- Programs
- 26
- Drugs
- 12
- Patents
- 38
Aldeyra Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Aldeyra Therapeutics.
Aldeyra Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Aldeyra Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.